The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.

The antiviral factor tripartite interaction motif 5alpha (Trim5alpha) restricts a broad range of retroviruses in a species-specific manner. Although human Trim5alpha is unable to block HIV-1 infection in human cells, a modest inhibition of HIV-1 replication has been reported. Recently two polymorphi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniëlle van Manen, Maarten A N Rits, Corrine Beugeling, Karel van Dort, Hanneke Schuitemaker, Neeltje A Kootstra
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2008
Materias:
Acceso en línea:https://doaj.org/article/7b1a1eb83b8b45e39f23fa13e36a2a56
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7b1a1eb83b8b45e39f23fa13e36a2a56
record_format dspace
spelling oai:doaj.org-article:7b1a1eb83b8b45e39f23fa13e36a2a562021-11-25T05:46:45ZThe effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.1553-73661553-737410.1371/journal.ppat.0040018https://doaj.org/article/7b1a1eb83b8b45e39f23fa13e36a2a562008-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18248091/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374The antiviral factor tripartite interaction motif 5alpha (Trim5alpha) restricts a broad range of retroviruses in a species-specific manner. Although human Trim5alpha is unable to block HIV-1 infection in human cells, a modest inhibition of HIV-1 replication has been reported. Recently two polymorphisms in the Trim5 gene (H43Y and R136Q) were shown to affect the antiviral activity of Trim5alpha in vitro. In this study, participants of the Amsterdam Cohort studies were screened for polymorphisms at amino acid residue 43 and 136 of the Trim5 gene, and the potential effects of these polymorphisms on the clinical course of HIV-1 infection were analyzed. In agreement with the reported decreased antiviral activity of Trim5alpha that contains a Y at amino acid residue 43 in vitro, an accelerated disease progression was observed for individuals who were homozygous for the 43Y genotype as compared to individuals who were heterozygous or homozygous for the 43H genotype. A protective effect of the 136Q genotype was observed but only after the emergence of CXCR4-using (X4) HIV-1 variants and when a viral load of 10(4.5) copies per ml plasma was used as an endpoint in survival analysis. Interestingly, naive CD4 T cells, which are selectively targeted by X4 HIV-1, revealed a significantly higher expression of Trim5alpha than memory CD4 T cells. In addition, we observed that the 136Q allele in combination with the -2GG genotype in the 5'UTR was associated with an accelerated disease progression. Thus, polymorphisms in the Trim5 gene may influence the clinical course of HIV-1 infection also underscoring the antiviral effect of Trim5alpha on HIV-1 in vivo.Daniëlle van ManenMaarten A N RitsCorrine BeugelingKarel van DortHanneke SchuitemakerNeeltje A KootstraPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 4, Iss 2, p e18 (2008)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Daniëlle van Manen
Maarten A N Rits
Corrine Beugeling
Karel van Dort
Hanneke Schuitemaker
Neeltje A Kootstra
The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
description The antiviral factor tripartite interaction motif 5alpha (Trim5alpha) restricts a broad range of retroviruses in a species-specific manner. Although human Trim5alpha is unable to block HIV-1 infection in human cells, a modest inhibition of HIV-1 replication has been reported. Recently two polymorphisms in the Trim5 gene (H43Y and R136Q) were shown to affect the antiviral activity of Trim5alpha in vitro. In this study, participants of the Amsterdam Cohort studies were screened for polymorphisms at amino acid residue 43 and 136 of the Trim5 gene, and the potential effects of these polymorphisms on the clinical course of HIV-1 infection were analyzed. In agreement with the reported decreased antiviral activity of Trim5alpha that contains a Y at amino acid residue 43 in vitro, an accelerated disease progression was observed for individuals who were homozygous for the 43Y genotype as compared to individuals who were heterozygous or homozygous for the 43H genotype. A protective effect of the 136Q genotype was observed but only after the emergence of CXCR4-using (X4) HIV-1 variants and when a viral load of 10(4.5) copies per ml plasma was used as an endpoint in survival analysis. Interestingly, naive CD4 T cells, which are selectively targeted by X4 HIV-1, revealed a significantly higher expression of Trim5alpha than memory CD4 T cells. In addition, we observed that the 136Q allele in combination with the -2GG genotype in the 5'UTR was associated with an accelerated disease progression. Thus, polymorphisms in the Trim5 gene may influence the clinical course of HIV-1 infection also underscoring the antiviral effect of Trim5alpha on HIV-1 in vivo.
format article
author Daniëlle van Manen
Maarten A N Rits
Corrine Beugeling
Karel van Dort
Hanneke Schuitemaker
Neeltje A Kootstra
author_facet Daniëlle van Manen
Maarten A N Rits
Corrine Beugeling
Karel van Dort
Hanneke Schuitemaker
Neeltje A Kootstra
author_sort Daniëlle van Manen
title The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
title_short The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
title_full The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
title_fullStr The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
title_full_unstemmed The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
title_sort effect of trim5 polymorphisms on the clinical course of hiv-1 infection.
publisher Public Library of Science (PLoS)
publishDate 2008
url https://doaj.org/article/7b1a1eb83b8b45e39f23fa13e36a2a56
work_keys_str_mv AT daniellevanmanen theeffectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT maartenanrits theeffectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT corrinebeugeling theeffectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT karelvandort theeffectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT hannekeschuitemaker theeffectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT neeltjeakootstra theeffectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT daniellevanmanen effectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT maartenanrits effectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT corrinebeugeling effectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT karelvandort effectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT hannekeschuitemaker effectoftrim5polymorphismsontheclinicalcourseofhiv1infection
AT neeltjeakootstra effectoftrim5polymorphismsontheclinicalcourseofhiv1infection
_version_ 1718414464415432704